GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Days Inventory

OSTX (OS Therapies) Days Inventory : 0.00 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OS Therapies Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). OS Therapies's Average Total Inventories for the three months ended in Sep. 2024 was $0.00 Mil. OS Therapies's Cost of Goods Sold for the three months ended in Sep. 2024 was $0.00 Mil.

The historical rank and industry rank for OS Therapies's Days Inventory or its related term are showing as below:

OSTX's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 188.02
* Ranked among companies with meaningful Days Inventory only.

OS Therapies's Days Inventory stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

OS Therapies Days Inventory Historical Data

The historical data trend for OS Therapies's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OS Therapies Days Inventory Chart

OS Therapies Annual Data
Trend Dec21 Dec22 Dec23
Days Inventory
- - -

OS Therapies Quarterly Data
Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OS Therapies's Days Inventory

For the Biotechnology subindustry, OS Therapies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OS Therapies's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OS Therapies's Days Inventory distribution charts can be found below:

* The bar in red indicates where OS Therapies's Days Inventory falls into.


OS Therapies Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

OS Therapies's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

OS Therapies's Days Inventory for the quarter that ended in Sep. 2024 is calculated as:

Days Inventory (Q: Sep. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2024 ) + Total Inventories (Q: Sep. 2024 )) / count ) / Cost of Goods Sold (Q: Sep. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OS Therapies  (AMEX:OSTX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

OS Therapies's Inventory Turnover for the three months ended in Sep. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0 / 0
=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

OS Therapies's Inventory to Revenue for the three months ended in Sep. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

OS Therapies Days Inventory Related Terms

Thank you for viewing the detailed overview of OS Therapies's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

OS Therapies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Days Inventory
Comparable Companies
Traded in Other Exchanges
N/A
Address
15825 Shady Grove Road, Suite 135, Rockville, MD, USA, 20850
Website
https://www.ostherapies.com
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.